Canaan Partners

Founded in 1987, Canaan Partners is a global venture capital firm based in Menlo Park, California. With over $5 billion under management, the firm invests in early-stage technology and healthcare companies worldwide.

Brenton Ahrens

General Partner - West Coast

Brent Ahrens

General Partner

Nandu Anilal

Investor

John Balen

General Partner

Joydeep Bhattacharyya

General Partner

Past deals in North Carolina

Mosey

Venture Round in 2022
Mosey is a compliance platform designed to assist businesses in managing employment and tax requirements across all 50 states and over 100 cities in the United States. Founded by Matthew Loyd and Eric Persha, the company provides an affordable solution for organizations looking to scale remote work while ensuring compliance with varying regulations. The platform streamlines the often manual processes associated with human resources, enabling companies to confidently hire employees from diverse locations. Mosey's services cater to HR teams seeking efficient ways to navigate complex compliance landscapes, thus facilitating growth and operational flexibility in a dynamic workforce environment.

Mosey

Seed Round in 2021
Mosey is a compliance platform designed to assist businesses in managing employment and tax requirements across all 50 states and over 100 cities in the United States. Founded by Matthew Loyd and Eric Persha, the company provides an affordable solution for organizations looking to scale remote work while ensuring compliance with varying regulations. The platform streamlines the often manual processes associated with human resources, enabling companies to confidently hire employees from diverse locations. Mosey's services cater to HR teams seeking efficient ways to navigate complex compliance landscapes, thus facilitating growth and operational flexibility in a dynamic workforce environment.

Kustomer

Series C in 2019
Founded in 2015, Kustomer develops a SaaS CRM platform for enterprise-level customer service. Its platform unifies data from multiple sources, enabling companies to deliver service through a single timeline view. It serves leading brands such as Ring and Glossier.

Kustomer

Series B in 2018
Founded in 2015, Kustomer develops a SaaS CRM platform for enterprise-level customer service. Its platform unifies data from multiple sources, enabling companies to deliver service through a single timeline view. It serves leading brands such as Ring and Glossier.

Kustomer

Series A in 2016
Founded in 2015, Kustomer develops a SaaS CRM platform for enterprise-level customer service. Its platform unifies data from multiple sources, enabling companies to deliver service through a single timeline view. It serves leading brands such as Ring and Glossier.

LQ3 Pharmaceuticals

Series A in 2014
LQ3 Pharmaceuticals, Inc. is a healthcare company based in Morrisville, North Carolina, specializing in the development of oral health therapies. Established in 2013, the company employs advanced PRINT (Particle Replication In Non-Wetting Templates) technology to research and create innovative solutions for various oral health issues. By focusing on this niche within the pharmaceutical sector, LQ3 Pharmaceuticals aims to enhance the dental industry through the application of cutting-edge technology and effective therapeutic products.

Envisia Therapeutics

Series A in 2013
Envisia Therapeutics Inc. is a company focused on discovering and developing innovative therapies for ophthalmic medical needs. Founded in 2013 and based in Durham, North Carolina, the company utilizes its proprietary Particle Replication In Non-Wetting Templates (PRINT) technology to create a range of particle-based therapies. Envisia is particularly known for its lead product, ENV515, a prostaglandin analogue designed to deliver sustained intraocular pressure reduction for extended periods. In addition to this, the company is developing glaucoma drug therapies that leverage PRINT particle therapeutics to improve drug delivery and efficacy while addressing common barriers faced by existing ocular treatments. As the demand for more effective ocular therapeutics continues to grow, Envisia aims to enhance patient outcomes and convenience in the management of ocular diseases.

UnitedLex

Secondary Market in 2011
Founded in 2006, UnitedLex is a global provider of technology-powered legal and business solutions. It offers services such as litigation support, electronic data discovery, document review, contract management, intellectual property solutions, compliance services, and law department consultancy to corporate clients and law firms worldwide.

Axial Exchange

Series A in 2011
Axial Exchange is a healthcare technology company that develops a remote patient and population health monitoring and communications platform. The platform delivers real-time insights into patients' health status, data, and behavior to support care teams between encounters, enabling early detection of complications and more engaged patients. Through mobile apps, it facilitates secure sharing of health information with providers and caregivers, with the aim of improving patient outcomes and reducing hospital admissions and overall healthcare costs via early intervention and coordinated care. The company was founded in 2009 and is based in Raleigh, North Carolina.

Chimerix

Series F in 2011
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

Chimerix

Series E in 2009
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

UnitedLex

Series B in 2008
Founded in 2006, UnitedLex is a global provider of technology-powered legal and business solutions. It offers services such as litigation support, electronic data discovery, document review, contract management, intellectual property solutions, compliance services, and law department consultancy to corporate clients and law firms worldwide.

Chimerix

Series D in 2007
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

Everdream

Series F in 2005
Everdream Corporation is a provider of on-demand desktop management software services, specializing in managed services for compliance and uptime. The company offers a comprehensive suite of software solutions that deliver visibility into hardware and software assets, track software license usage, and automate software distribution to ensure regulatory compliance. Additionally, Everdream provides essential protection against Internet attacks, hackers, and data loss through services such as malware protection, patch management, and online data backup. The company also offers IT support solutions, including on-demand employee service desk options and remote control services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc.

Everdream

Series D in 2003
Everdream Corporation is a provider of on-demand desktop management software services, specializing in managed services for compliance and uptime. The company offers a comprehensive suite of software solutions that deliver visibility into hardware and software assets, track software license usage, and automate software distribution to ensure regulatory compliance. Additionally, Everdream provides essential protection against Internet attacks, hackers, and data loss through services such as malware protection, patch management, and online data backup. The company also offers IT support solutions, including on-demand employee service desk options and remote control services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc.

Everdream

Series C in 2000
Everdream Corporation is a provider of on-demand desktop management software services, specializing in managed services for compliance and uptime. The company offers a comprehensive suite of software solutions that deliver visibility into hardware and software assets, track software license usage, and automate software distribution to ensure regulatory compliance. Additionally, Everdream provides essential protection against Internet attacks, hackers, and data loss through services such as malware protection, patch management, and online data backup. The company also offers IT support solutions, including on-demand employee service desk options and remote control services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc.

Everdream

Series B in 2000
Everdream Corporation is a provider of on-demand desktop management software services, specializing in managed services for compliance and uptime. The company offers a comprehensive suite of software solutions that deliver visibility into hardware and software assets, track software license usage, and automate software distribution to ensure regulatory compliance. Additionally, Everdream provides essential protection against Internet attacks, hackers, and data loss through services such as malware protection, patch management, and online data backup. The company also offers IT support solutions, including on-demand employee service desk options and remote control services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc.

Synchronicity

Venture Round in 2000
Synchronicity is a Charlotte, NC-based creative digital marketing agency that has been delivering professional online strategies, website design, and development services since 1998. The company specializes in creating and promoting high-quality websites, focusing on designing digital platforms and branded experiences that align with client objectives and consumer needs. Synchronicity emphasizes direct collaboration with its clients to craft unique and engaging experiences, helping them solve business challenges and enhance visibility. Additionally, Synchronicity develops software solutions aimed at improving the integrated circuit design process, serving semiconductor and embedded software developers. The company provides design management and collaboration tools that facilitate the handling and distribution of large-scale electronic designs across multiple locations, thereby enhancing design productivity and efficiency for its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.